Blog
Types of myopia control, compared
Types of myopia control, compared.
There are four evidence-based ways to slow a child’s nearsightedness. Here is what each one does, what it asks of your family, and how we decide which fits.
When your child’s prescription gets stronger every year, it is tempting to treat it as a glasses problem: the numbers went up, so we update the lenses. But a rising myopia number means the eye itself is growing longer, and a longer eye carries a higher lifetime risk of retinal detachment, myopic maculopathy, glaucoma, and earlier cataracts.
Myopia control is the set of treatments designed to slow that growth, not just sharpen vision for the day. We cannot stop nearsightedness. We can slow how fast it progresses, and the earlier we start, the more eye growth there is left to influence.
At COVE in New Albany we use four myopia-control options. None of them is the single right answer for every child. The right choice depends on your child’s prescription, age, and maturity, their sports and screen habits, and what your family can realistically keep up with. Here is each one, what it asks of you, and how we help you choose.
Controlling myopia is not the same as correcting it.
A standard pair of glasses or contacts corrects vision: it bends light so the image lands sharply on the retina today. That is genuinely useful, but ordinary single-vision correction does nothing to slow how fast the eye is lengthening.
Myopia control treatments are designed differently. Each one changes the way light focuses across the whole retina, not just the center, or uses a low-dose medication to influence the eye’s growth signal. The shared goal is to slow axial elongation while still giving the child clear vision to live and learn with.
That is the lens to read the next section through. We are not comparing which option gives the sharpest vision. We are comparing how each one slows the underlying progression, and what it costs a family in routine and effort.
We cannot stop nearsightedness. We can slow it. The earlier we start, the more eye growth there is left to influence.
The four options we use, side by side.
Two are lenses you can see, one is worn only while a child sleeps, and one is a drop. Here is the short version of all four. Treatment names link out to the deeper pages where each is covered in full.
Stellest (Essilor) spectacle lenses are the easiest behavior change for a child who already wears glasses. The lens looks ordinary but is designed to slow axial elongation while correcting vision normally.
MiSight 1 day (CooperVision) is an FDA-approved soft daily contact lens for slowing myopia progression in eligible children, roughly 8 to 12 at the start and with otherwise healthy eyes. It suits a child who is ready for contacts during the day but not ready for overnight wear.
Orthokeratology (Ortho-K) uses rigid lenses worn only overnight to gently reshape the cornea while a child sleeps. They wake up to clear vision with no daytime glasses or contacts, which is why it is a strong fit for swimmers and sports kids.
Low-dose atropine is a nightly drop that influences the eye’s growth signal. It is useful for younger children not yet ready for contacts, and it can be combined with glasses or other options. Atropine for myopia is generally prescribed off-label, and the low-dose versions are often compounded, so we walk through what that means for your family. It is also a particular focus of my clinical work here at COVE.
How we match a treatment to a child.
At the consultation we map the cornea, review the prescription and how fast it has changed, and talk through the child’s day. A few factors do most of the deciding:
Sometimes the answer is a combination. Atropine pairs well with Stellest glasses, for example, when a single option is not slowing progression enough on its own. We also build remake terms around growing eyes: Stellest lenses can be remade at half a diopter of change, Ortho-K lenses are remade until the fit is right, and MiSight supply can be exchanged when the prescription shifts.
What progress looks like over the first year.
Myopia control is measured over months and years, not days. The vision benefit of any option shows up quickly, but the thing we are really watching, the rate of eye growth, can only be judged across regular checkpoints.
In a typical first year we see a child at one week, one month, three months, and six months. At each visit we confirm vision, check eye health, and compare the prescription against the trend line. If progression is still moving faster than we want, that is when we adjust: change the option, or add a second one.
If your child’s prescription keeps climbing, a consultation is the place to find out which of these four fits. No commitment, and an honest answer either way.
Talk to us about your child’s myopiaOr call us at (614) 933-0575. We see families from New Albany, Gahanna, Westerville, and Johnstown.
Common questions.
Q.01 What is the difference between correcting myopia and controlling it?
Correcting myopia means giving clear vision today with standard glasses or contacts. Controlling it means slowing how fast the eye is lengthening, which is what raises long-term eye health risk. Myopia control treatments do both: they correct vision and slow progression.
Q.02 At what age should myopia control start?
As soon as a child’s nearsightedness is clearly progressing. The earlier we begin, the more eye growth there is left to slow. There is no strict minimum age for treatment; the deciding factor is whether progression has started and which option a child can manage.
Q.03 Which option is the most effective?
All four have a meaningful evidence base for slowing progression, and head-to-head results vary by child. The most effective option in practice is the one a child uses consistently and that fits their eyes and their life, which is why we choose it together at the consultation rather than name a universal winner.
Q.04 Can these treatments be combined?
Yes, in some cases. Low-dose atropine is often paired with Stellest glasses or with contact lens options when a single treatment is not slowing progression enough on its own. We decide whether to combine based on how the eye responds over the first months.
Q.05 Does insurance cover myopia control?
Coverage varies by plan and by option. Some vision plans contribute toward specialty contact lens fits; others treat myopia control as elective. We verify what we can about your plan in advance and review expected benefits, qualification, and costs together at the consultation. Families without a vision plan can ask about COVE Plus.
Q.06 What happens if we stop treatment?
Stopping any of these treatments ends its ongoing effect: the eye doesn’t un-grow, and progression can resume, which is why we keep monitoring either way. We think of myopia control as something to maintain through the years when the eye is still growing, rather than a one-time fix.